Based on our extremely encouraging experience to date, we propose to pursue proton beam therapy for the treatment of cancer. We will continued randomized clinical trials of proton vs. x-ray therapy for stage T3-4 carcinoma of the prostate and for carcinoma of the floor of mouth and base of tongue. We will continue our non-randomized trials of proton beam therapy of chordomas and chondrosarcomas of the base of skull and cervical spine and of choroidal melanomas. We will determine whether the excellent local results seen to date with these sites is maintained. We plan two-dose randomized trials in selected patients in both these categories. We are planning new clinical trials in the treatment of paraaortic lymph node disease; meningiomas; superior sulcus tumors; acoustic neuromas; large choroidal melanomas; and anal and rectal tumors. We will take advantage of the unusual dose distributions obtained with proton beams to get clinical data concerning the tolerance of sensitive organs to partial volume irradiation and will correlate any observed treatment complications with the dose delivered to the sites involved. We will continue improvements in our capability to plan and deliver proton beam treatments with the goal of making possible the wider clinical dissemination of this treatment modality. One such project is to investigate the possibility of a """"""""no touch"""""""" technique for the treatment of choroidal melanomas. The primary objective of the study is to evaluate whether the improvement in dose distributions achievable with proton beam therapy can be used to deliver an increased dose to the tumor with no greater and potentially less morbidity, and whether such an increased dose will lead to improvements in local control of cancer. If this program continues to demonstrate the advantages of protons which have been experienced to date, it will provide an important therapeutic option for several cancers which pose great difficulties for conventional treatment techniques.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA021239-09
Application #
3092943
Study Section
(SRC)
Project Start
1985-08-01
Project End
1990-07-31
Budget Start
1985-08-01
Budget End
1986-07-31
Support Year
9
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
Pulsifer, Margaret B; Duncanson, Haley; Grieco, Julie et al. (2018) Cognitive and Adaptive Outcomes After Proton Radiation for Pediatric Patients With Brain Tumors. Int J Radiat Oncol Biol Phys 102:391-398
Liao, Zhongxing; Lee, J Jack; Komaki, Ritsuko et al. (2018) Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer. J Clin Oncol 36:1813-1822
Jeter, Melenda D; Gomez, Daniel; Nguyen, Quynh-Nhu et al. (2018) Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A P Int J Radiat Oncol Biol Phys 100:730-737
Frank, Steven J; Blanchard, Pierre; Lee, J Jack et al. (2018) Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation. Semin Radiat Oncol 28:108-113
Lin, Yu-Fen; Chen, Benjamin P; Li, Wende et al. (2018) The Relative Biological Effect of Spread-Out Bragg Peak Protons in Sensitive and Resistant Tumor Cells. Int J Part Ther 4:33-39
Ning, Matthew S; Tang, Linglong; Gomez, Daniel R et al. (2017) Incidence and Predictors of Pericardial Effusion After Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 99:70-79
Chang, Joe Y; Zhang, Wencheng; Komaki, Ritsuko et al. (2017) Long-term outcome of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer. Radiother Oncol 122:274-280
Sanford, Nina N; Yeap, Beow Y; Larvie, Mykol et al. (2017) Prospective, Randomized Study of Radiation Dose Escalation With Combined Proton-Photon Therapy for Benign Meningiomas. Int J Radiat Oncol Biol Phys 99:787-796
Taylor, Paige A; Kry, Stephen F; Followill, David S (2017) Pencil Beam Algorithms Are Unsuitable for Proton Dose Calculations in Lung. Int J Radiat Oncol Biol Phys 99:750-756
Yock, Torunn I; Yeap, Beow Y; Ebb, David H et al. (2016) Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study. Lancet Oncol 17:287-98

Showing the most recent 10 out of 260 publications